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Judd Lecture 
Portal Hepatotrophic Factors: 
A Century of Controversy 
Thomas E. Stanl, M.D., Ph.D. 
For this Judd Lecture, I would like to emphasize some of our work that 
has broad implications in physiology as well as in medicine and surgery. It 
is not a talk on transplantation. But what I will have to say should be of 
interest to liver transplanters and to those employing shunt procedures to 
decompress esophageal varices. It should also provide insight into some 
really important advances in the treatment of certain inborn errors of 
metabolism, as well as probably having some application to liver 
regeneration. This will be a review of one of the most persistently 
controversial problems in experimental surgery and hepatic physiology, 
namely, whether or not there are specific factors in the venous blood 
flowing up through the portal vein that are of any importance in the 
maintenance of liver structure and function. 
Anatomical Notes 
There may be some for whom a brief anatomical review is in order. 
The double blood supply of the liver consists of a hepatic artery which, of 
course, transmits completely mixed blood from the heart, and the portal 
vein which contains less completely mixed blood from the various 
splanchnic viscera. About 20% or 25% of the blood coming 'to the liver is 
brought by the hepatic artery and the other three-quarters to four-fifths 
comes in the portal blood supply. The double blood supply is retained 
down to the smallest structural unit of the liver, the lobule. 
The capillary circulation of the liver and the means by which the two 
aforementioned separate sources of blood are brought to bear on the same 
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capillary bed has been clarified in recent years. Both the arterial and portal 
venous branches perfuse the hepatic sinusoids lined with Kupffer cells, 
drain into the lobular central veins, and then into the larger hepatic veins 
and on to the heart. The portal blood supply is intimately related to the 
hepatocytes of the so-called limiting plate. These hepatocytes are rich in 
pentose nucleic acids, and they are the most active centers of regeneration. 
Variations in the relative quantity of blood from the portal vein and the 
hepatic artery can be imposed by vascular sphincters. 
Historical Vignettes 
From some of the anatomical features I have just described, most 
old-time biologists concluded that there was a special reason for the 
interposition of the liver between the splanchnic viscera and the heart. It is 
obvious that the special ingredients could include alimentary nutriments 
(mainly from the intestines) or hormones (from both the pancreas and 
bowel). A teleologist of the old days might also have concluded, and most 
did, that diversion of the portal venous blood around the liver should have 
been incompatible with life. 
It was at this point that the famous paper of Nicholas Eck arrived on 
the scene and thoroughly upset the apple cart. Eck's article was published 
in the Military Medical Journal, Moscow, of 1877 [1]. It consisted of 
about one page. First, it described the technique of the operation by 
which the portal vein and vena cava could be anastomosed, thereby 
diverting the portal blood past the liver. Second, it described eight dog 
experiments. Seven of the animals died within one week, leaving a single 
chronic survivor. 
This sole experimental subject lived for about O~ months and ran 
away from the dog farm. Doctor Eck obviously envisioned the possible 
clinical use of his venous fistula, since he discussed its possible application 
for the treatment of ascites in humans. He said, "I consider the main 
reason to doubt that such an operation can be carried out on human 
beings has been removed because it was established that the blood of the 
portal vein, without any danger to the body, could be diverted directly 
into the general circulation and this by means of a perfectly safe 
operation," a not atypical surgical exaggeration since the mortality had 
been 88%. Doctor Eck was never heard from again in scientific circles, but 
the ripples from his innocent manuscript have continued to agitate surgical 
and physiologic waters for almost a century, involving many scientific 
great names in the process. 
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Eck's disanning conclusion of the safety of Eck fistula was challenged 
in 1893 by Hahn and his co-workers, including the famous Pavlov of St. 
Petersburg, Russia' [2J. Hahn and Pavlov described the syndrome in dogs 
which soon came to be called meat intoxication because it could be caused 
or made worse by eating meat. Animals affected by this disorder 
developed lethargy, ataxia, convulsions and death. 
The essential technical feature of Eck's fistula was the coaptation of 
the portal vein and vena cava with two rows of interrupted sutures. Then, 
the tissue between the anterior and posterior rows of sutures was either 
ripped out or cut out by a pull-out suture inserted with a special 
instrument. The crude nature of the anastomotic technique made it 
difficult or impossible to conSistently ensure a wide open anastomosis as 
can be routinely achieved with vascular suture techniques today. The 
inconsistency of resuits by different workers with Eck fistula probably 
was, therefore, partly explained by variations in the size of the resulting 
hole created between the vessels. 
The work of Pavlov and Hahn tilted the balance back slightly toward 
the concept that there were factors in the portal blood that were at least 
important, if not vital, for the support of liver structure and function, as 
did also the publications of Rous and Larimore [3] who were fascinated 
with the atrophy affecting the liver after the performance of Eck fistula. 
In a statement made in 1920, Rous and Larimore said: "If so, its 
completeness (that is, the atrophy) would indicate that the liver has no 
essential activity - none on which its maintenance depends - that is not 
intimately connected with substances derived from organs drained by the 
portal system." 
The somewhat mystical concept of Rous and Larimore was neither 
supported nor denied by the works and writings of Dr. F. C. Mann of the 
Mayo Clinic, who in a summary of his work presented at the Mount Sinai 
Hospital, New York, in 1944, said, "We have made several investigations 
for the purpose of determining if a specific physiologic stimulus is 
responsible for hepatic restoration. None has been found to date. The 
results of all of our experiments appear to indicate that the restoration of 
the liver after partial removal is dependent upon the flow of portal blood 
through the organ. It appears that the restoration of hepatic tissue occurs 
primarily in order to maintain the portal pathways and the restoration of 
functioning hepatic tissue is secondary" [4] . In many ways this hypothesis 
of Mann has dominated all thinking about hepatic physiology until very 
recently. To put it more clearly, it seemed to state that the important 
factor in portal blood flow was not the qualitative characteristics of the 
blood but rather its quantity. 
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FIG. 1. Technique of portacaval transposition performed on a child in October 1963, 
in an effort to alleviate the symptoms of glycogen storage disease. Note that all the 
portal blood is diverted around the liver but that vena caval blood is used to replace 
this loss. (By permission of Surgery, 57 :687,1965.) 
The flow theory seemed to derive crucial or even incontrovertible 
support from a paper which is truly a classic, authored by C. Gardner 
Child who retired last June as Chairman of the Department of Surgery at 
the University of Michigan. The paper was published in 1953 [5]. 
With this operation which, incidentally, is shown in Figure 1 as carried 
out in a human, the splanchnic venous blood is diverted by an end-to-end 
anastomosis to the vena cava flowing behind the liver, but the lost portal 
blood is replaced with an inflow to the hilar portal vein from the inferior 
vena cava. With the blood flow replacement, Child avoided in dogs most of 
the adverse effects of Eck fistula. The concept became completely 
accepted that the quality of portal venous inflow was not a prime 
determinant for ·good hepatic function, structure or the capacity for 
regeneration. Instead, it now became the fashionable dogma that the 
quantity of total blood flow was the main consideration. 
The numerous publications of Dr. Bernie Fisher, today a Professor of 
Surgery at the University of Pittsburgh, were particularly persuasive in 
support of the flow hypothesis. In one of Fisher's publications from 1954, 
data appeared to show that the capacity of regeneration of a partially 
resected dog liver was, if anything, gre,ater than normal when splanchnic 
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FIG. 2. Mean changes in liver glycogen concentration in 17 dogs following portacaval 
transposition. Vertical lines represent ±1 standard error. (By permission of Surgery, 
57:687,1965. 
vencus blood was diverted and replaced by arterial blood [6] . For reasons 
still not understood, it is now my opinion that these observations, as well 
as other later ones by Fisher, were either incorrect or else misinterpreted 
by him. 
I found it hard to believe the flow hypothesis and in 1958 I submitted 
a research application from Northwestern University (Chicago) for 
$28,000. The application proposed to determine if subtle changes were 
not brought about by portal diversion, specifically affecting carbohydrate 
and insulin metabolism. It was suggested that portal diversion procedures 
might help disease states of carbohydrate metabolism such as diabetes 
mellitus (and also glycogen storage disease). It alluded to an interplay 
between the liver and incoming blood-borne endocrine factors. And, as a 
bonus, it promised to deliver a new method of creating cirrhosis in dogs. 
Actually, the grant contributed little to the subject of hepatotrophic 
factors except for the kinds of data shown in Figure 2. The dogs which 
provided this information [7] underwent Child's portacaval transposition 
and afterwards were perfectly healthy. Nevertheless, the total and labile 
liver glycogen within approximately a month fell to about half of its 
previous value. In many of these animals the total hepatic blood flow was 
measured and found to be essentially normal. Thus, there were easily 
demonstrable major changes in these livers effected by the loss of portal 
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blood even though there was replacement with vena caval blood, a vital 
clue pointing to the existence of portal blood factors. 
The Challenge to the Flow Hypothesis 
However, the most significant step in reopening the hepatotrophic 
issue was taken during laboratory efforts to evaluate auxiliary liver 
homotransplantation for the treatment of patients with non-neoplastic 
hepatic disease such as cirrhosis. The auxiliary operation was that 
originally described by C. Stuart Welch of Albany [8] . It involved the 
transplantation of an extra canine liver in the right paravertebral gutter or 
the pelvis of a nonrelated mongrel recipient. The hepatic arterial supply 
was derived from the iliac artery. Portal venous inflow was reconstituted 
by anastomosing the distal inferior vena cava to the homograft portal vein, 
providing a blood supply for this extra liver much the same as with Child's 
transposition (Fig. 3). Outflow was into the vena cava. In our laboratory in 
1963, auxiliary transplantation in immunosuppressed canine recipients 
(using Imuran) was attempted for the first time and with very curious 
results [9]. It was soon found that these auxiliary homografts underwent 
rapid shrinkage which was usually evident within two weeks and which 
was very advanced at all times after one month (Fig. 4). The gross 
appearance and lobar proportions of the now diminutive homografts 
remained relatively unaltered except for size. The duct system was spared 
from the shrinkage. But within the parenchyma, there was massive loss of 
hepatocytes from focal or widespread necrosis, reticulum collapse and the 
consequent crowding together of intrahepatic portal tracts. The blood 
flow in these auxiliary transplants was shown by Daloze, one of our 
Canadian Fellows, to be actually greater than in the native liver [10] . 
Thus, the remarkable atrophy was not compatible with the blood flow 
hypothesis of Child and Fisher. Instead, it was speculated from the 
beginning "that competition of the homograft with the dog's own liver for 
nutritional or some other portal substrate may have been an unfavorable 
condition" [9]. 
We supported the hypothesis of competition between co-existing livers 
the following year in a paper by Marchioro in 1965 [11]. In these 
experiments canine homografts were placed in the right paravertebral 
gutter the same way as with the classical Welch procedure except that the 
portal vein of the homograft was connected to the superior mesenteric 
vein of the recipient (Fig. 3B). Splanchnic flow through the auxiliary liver 
was then promoted by ligating the portal vein at the hilum of the host 
liver. 
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FIG. 3. Auxiliary liver homotransplantation. (A) Modification of Welch technique. 
Homograft undergoes rapid atrophy. Portal blood flow is from the systemic venous 
system. (B) Modification whereby splanchnic venous flow is diverted to the 
homograft. With this preparation, the homograft retains its size and the animal's own 
liver undergoes shrinkage. It is usually more convenient to bring the hepatic artery 
behind rather than in front of the portal vein as depicted. (By permission of Surgery, 
121: 17,1965.) 
FIG. 4. The auxiliary homograft (right) and the recipient dog's own liver (left), after 
the kind of transplantation shown in Figure 3A. The donor and recipient were of 
approximately the same size at the time of the original operation. Note the 
well-preserved but dimensionally reduced general structure of the homograft. The 
gallbladder did not shrink proportionately. The specimens were obtained 45 days 
after transplantation. (By permission of Annals of Surgery, 160:411,1964.) 
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These animals, which were also treated with azathioprine, now usually 
had atrophy of their own livers but not of the homografts. These donors 
and recipients had been of approximately the same size before operation 
but afterwards in most cases the dono! liver or homograft outweighed the 
native organ. 
Histopathologically, the characteristic injury suffered by the native 
liver which was starved of splanchnic blood consisted of centrilobular 
atrophy or variable cell necrosis, and collapse of the reticulin-supporting 
framework of the liver. 
I will not bore you with the details of confirmation of these fmdings 
except to say that important supporting studies in the auxiliary transplant 
model were made from our laboratories by Halgrimson [12] and 
Faris [13] and by Thomford [14] of the Mayo Clinic and Tretbar [15] of 
the Cleveland Clinic all by 1966. However, the transplant preparations 
which had made apparent the foregoing physiologic effects had two 
serious flaws which prevented the hepatotrophic concept from being 
accepted by many observers. First, the total flows delivered to the two 
co-existing livers were often different. Second, there was by definition an 
additional inherent inequality of the two organs, since the homograft was 
often under immunologic attack despite host immunosuppression, whereas 
the animal's own liver was not. Consequently, we undertook other 
experiments which were designed to circumvent one or both deficiencies. 
FIG. s. Partial (split) portacaval transposition. Note that the entire vena caval flow is 
directed into either the left or right portal venous branch. (By permission of Surgery, 
Gynecology and Obstetrics, 137:179, 1973.) 
-- -
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Partial Portacaval Transposition 
The key paper introduced what has been since termed a split or partial 
transposition [16]. With this operation, splanchnic venous blood is 
provided for one portal branch of the liver, whereas the other portal 
branch is detached and supplied with olood from the inferior vena cava 
(Fig. 5). The quantity of flow was measured in many of these experiments 
and found to be invariably greater on the side perfused by vena caval 
blood. 
The results from this work were extremely clear cut and in 
morphologic terms are summarized in Figure 6. In these experiments the 
right liver lobes which normally constitute about 30% of the total liver 
mass had vena caval inflow. These lobes were smaller than the anticipated 
30%, indicating atrophy. The left lobes receiving splanchnic blood were 
larger than the expected 70% normal contribution to total liver mass, 
indicating hypertrophy. 
In mirror image experiments, the right lobes received portal venous 
inflow and now had become much larger than their normal 30% during the 
30- to 60-day period of observation. The left lobes which received 
systemic venous input from the vena cava underwent atrophy down from 
the expected 70%. Histopathologic and biochemical analyses of these liver 
~ o 
f-
I 
<.9 
W 
:s: 
.J 
~ 
80 
o 30·-Fc..:;..;;.;::..;..:;.;;;.;;,-== 
f-
o 
f- 20 
o 
~ 10 
Ct: 
O.L...--
Inferior Vena Cova- Right Branch of Porto I 
Vein Anastomosis 
FIG. 6. Results with the kind of partial portacaval transposition depicted in Figure 
SB. Note the atrophy of the right lobes supplied with vena caval blood and the 
hypertrophy of the left lobes which were receiving splanchnic venous blood. The 
results were abstracted from the original article by Marchioro et al [161. 
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fragments showed that the advantaged lobe complexes which were 
receiving splanchnic venous blood had hypertrophy of the individual 
hepatocytes, that these hepatocytes were also undergoing hyperplasia and 
that the hepatocytes were glycogen-rich. 
Findings of Other Authors 
These original papers describing split transposition were published in 
1965 and 1967. Within a year or two, J. B. Price of Columbia [17] , Sun 
Lee and James Chandler of San Diego [18, 19] and ther associates 
performed analogous experiments exploiting the qualities of the double 
liver fragment model. Price used canine partial hepatic autografts and Lee 
and Chandler used isografts of inbred rat livers. All of these experiments 
showed hypertrophy in the hepatic tissue which was perfused ~ith 
splanchnic blood and atrophy of the other hepatic fragments. In addition, 
with quantitative studies of DNA synthesis. Lee and Chandler provided 
further evidence that the hepatotrophic effects of splanchnic venous blood 
upon the liver included hyperplasia as well as hypertrophy [19]. By this 
time, it had become increasingly accepted that portal hepatotrophic 
factors were probably not just artifacts of transplantation and other 
experimental maneuvers, but were prime determinants of the initiation 
and control of liver hypertrophy and hyperplasia in many circumstances, 
presumably including regeneration. 
However, claims of the hepatotrophic factor concept were not received 
by the surgical community with unmitigated joy. The most vigorous 
resistance came from Dr. Bernie Fisher of Pittsburgh who, in a widely 
quoted paper published in 1967, vigorously criticized the hepatotrophic 
hypothesis [20]. He presented data purporting to indicate that his 
previous position about the primacy of flow had been once more 
vindicated. The summary of this article began, "Studies of auxiliary liver 
transplantation have revived the concept that portal blood contains 
specific nutrients essential for the maintenance of the morphologic and 
functional integrity of hepatic tissue. Prior investigations from this and 
other laboratories provided no support to such a contention. It was 
concluded from these studies that the volume of flow via the portal system 
was the essential factor." Since the perpetrators of this controversy were 
identified as being from our Colorado group, we had all begun to feel more 
than a little nervous at our apparent adversary relationship to such a 
distinguished surgical scientist. 
Consequently, it was with no small relief, to say nothing of amazement 
when scarcely three years later, Fisher published the first of two 
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papers [21] in support of that very concept to which he had been 
previously implacably opposed. In rats, he had exploited the double liver 
fragment model originally developed with auxiliary liver transplantation 
and then carried out partial resections of one or the other of these 
co-existing livers. The critical observation was that the liver remnant 
receiving systemic blood did not regenerate well at all. In discussing these 
results, Fisher conceded that . . . "The conclusion from this study that 
there is a portal blood factor which is capable of stimulating hepatic 
parenchymal cell replication might seem to be in conflict with other 
findings previously reported from this laboratory." 
I hope I will not be accused of small-mindedness in making the Fisher 
saga a subplot to the larger story of hepatotrophic substances which I am 
attempting to tell. I have mentioned Fisher only to indicate that 
sometimes the most outspoken critics of an idea became its most ardent 
advocates. When that occurred, thanks to the clever exploitation of the 
double liver fragment model, opposition to the hepatotrophic concept 
markedly diminished. Most students of hepatology began to concede the 
qualitative specialness of portal venous blood. But, now, I would like to 
look to three additional questions concerning the source, the nature and 
the mechanism of action of these special hepatotrophic substances. 
Recent Experiments With Partial 
Portacaval Transposition 
One approach was simply to do biochemical analyses of the regional 
liver tissues that were receiving different kinds of portal venous input, 
using again the split transposition model (Fig. 5). The differences in 
glycogen I mentioned earlier were highly quantifiable, as summarized in 
Table 1, from a batch of experiments in which the splanchnic venous 
blood went to the right lobes. * In addition to having higher glycogen 
concentration, the right or splanchnic-fed lobes had more glucokinase and 
lower concentrations of cyclic AMP and active phosphorylase. Of course, 
the glycogen, cyclic AMP and glucokinase findings all suggested that the 
right or hypertrophic lobes were being affected by endogenous insulin. It 
could be equally well suggested that the increased cyclic AMP and active 
phosphorylase in the left lobes were attributable to the adrenal epineph-
rine content of the insulin-poor vena caval blood supplying these lobes. In 
any event, a reasonable generalization would be that these two liver sides 
were living in different metabolic environments in which hormone control 
played a significant role [22]. 
*The full data from these experiments have been published [22]. 
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Table 1. Biochemical Dissociation Following the Kind of 
Split Transposition Depicted in Figure SA * 
Right 
Glycogen 3.7 mg/gm 
Glucokinase 3 micromoles/gm/min 
Cyclic AMP 1100 picomoles/gm 
Active Phosphorylase 55 millimicromoles/min/mg 
Left 
2.2 mg/gm 
1.7 micromoles/gm/min 
1700 picomoles/gm 
76 millimicromoles/min/mg 
*The data and statistical analyses are fully documented elsewhere [22] . 
Cyclic AMP concentration as an isolated measure gives a very limited 
view of the rate of cyclic AMP synthesis. Studies in which aminophylline 
was used to block the phosphodiesterase degradation of cyclic AMP 
demonstrated a greater synthetic rate in the vena caval lobes. However, the 
differences were not great and they were not obvious for several 
minutes [22] . 
Consequently, another dynamic study was devised to demonstrate the 
biochemical dissociation under special pharmacologic conditions [22] . In 
the preliminary experiment shown in Figure 7, intravenous tolbutamide 
was given to induce the release of endogenous insulin. Using a radio-
immunoassay technique, the insulin was found to rise sharply in the portal 
venous blood but with almost no detectable systemic increase. Thus, in 
these normal controls the background of endogenous insulin was standard-
ized. It is well known that insulin suppresses cyclic AMP formation. 
Then in dogs with the split transposition, an exogenous agent which 
acts by elevation of cyclic AMP, namely glucagon, was added to the 
tolbutamide challenge. The side which was receiving endogenous insulin 
from the splanchnic bed, whether this be on the right or left, had very 
minor cyclic AMP increases. In contrast, the liver tissue in which the 
infused glucagon could act in an uninhibited manner had unrestrained and 
colossal increases in cyclic AMP (Fig. 8). 
It is obvious that the foregoing circumstantial evidence again pointed 
at hormones, particularly pancreatic hormones, as the most important 
hepatotrophic factors. To further examine the hypothesis, dogs with the 
split transposition model shown in Figure SA were made diabetic either 
with alloxan or with total pancreatectomy and then treated with 15 to 20 
units NPH insulin for a two-month period of observation. The presence of 
either kind of treated diabetes slightly reduced the magnitude of 
hypertrophy of the right lobes (Fig. 9), but the hypertrophy was still 
significant compared to that in unoperated dogs. To put it differently, the 
removal of endogenous insulin or even the whole pancreas did not 
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FIG. 7. Changes in peripheral and portal venous insulin and hepatic cyclic 
P1IRD~adenosine monophosphate (cyclic AMP) occurring in a normal dog infused with 
tolbutamide. Note that the peak insulin response in the portal blood occurred 2540 
minutes after infusion and that no significant alterations in hepatic cyclic AMP were 
caused acutely by the tolbutamide itself. (By permission of Surgery, Gynecology and 
Obstetrics, 137:179,1973.) 
LOBES WITH SPLANCHNIC LoeES WITH VENA 
VENOUS INFLOW 
PMKoMM~--------D----------D 
LEFT 
25,000 
20,000 
15,000 
10,000 
5,000 
OMIlll~-------""----------D 
15,000 
10,000 
5,000 
LEFT 
.. 
.. 
~ 40'.····· 
02:46 602 
TIME AFTER BEGINNING GLUCAGON INFUSION 
(mill.) 
FIG. 8. Results of tolbutamide-glucagon tests in eight dogs with partial portacaval 
transposition, demonstrating the effect of endogenous insulin in the lobes receiving 
splanchnic venous blood. These insulin-controlled lobes had a restrained cyclic AMP 
response to the exogenous glucagon whereas the response in the other lobes was 
uninhibited. (By permission of Surgery, Gynecology and Obstetrics, 137: 179,1973.) 
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FIG. 9. Right and left liver lobe weights expressed as percentages of total liver mass 
in normal dogs and in dogs undergoing partial portacaval transposition (Fig. 5) with 
the splanchnic flow to the right lobes. About half of the operated animals were 
rendered diabetic, either by the prior administration of alloxan (four dogs) or by 
total pancreatectomy (six dogs). Note that the right lobes underwent remarkable 
hypertrophy and the left lobes atrophy after the transposition. This effect was only 
partially blunted by producing diabetes, less so by alloxan than by total 
pancreatectomy. N = Number of dogs in each experimental group. 
eliminate all or even most of the hepatotrophic effect of splanchnic venous 
blood, at least as revealed by this model. In the absence of endogenous 
insulin or of the whole pancreas, nutrient-rich intestinal blood was better 
for the liver than was systemic blood from the vena cava. Histopatho-
logically, this conclusion was even more striking. The left or so-called vena 
caval lobes contained hepatocytes that were fat laden. Although these 
were not particularly different in size than on the other side where 
perfusion was with splanchnic blood minus the pancreas, the tissue looked 
"sicker" on the vena caval side. Even the side receiving splanchnic flow 
had many abnormalities. 
When the diabetes was induced with alloxan instead of total 
pancreatectomy, the degree of injury to both liver sides was reduced. The 
hepatocytes on the side receiving vena caval blood still had increased fat 
but not so much as after total pancreatectomy. The hepatocytes on the 
side receiving splanchnic blood minus insulin were in even better 
condition, although again not normal. 
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FIG. 10. Technique of division of splanchnic venous flow into a pancreatico-
gastroduodenal-splenic compartment and an intestinal compartment. Blood from 
these respective sources is directed into the right or left lobes. The tail of the inferior 
lobe of the pancreas was resected since it drains separately into the mesenteric vein. 
(By permission of Surgery, Gynecology and Obstetrics, 137:179,1973.) 
Splanchnic Division Experiments 
All the experiments I have just shown are consistent with the 
interpretation that the splanchnic blood contains hepatotrophic factors. 
They also indicated that no single hormone or even single organ 
represented the sole hepatotrophic effect. To get some idea of the relative 
hepatotrophic effects of the different organs or hormones, surgical 
techniques were developed that partition.ed the splanchnic flow into its 
upper and lower components [22]. In some of these partitioning 
experiments (Fig. lOA), the right lobes of the liver were fed by a low 
volume of hormone-rich pancreatico-duodeno-splenic blood. By using a 
graft connecting the mesenteric vein to the left hepatic lobes, these left 
lobes were submitted to the somewhat greater volume of nutrition-rich 
blood returning from the intestine. In the dog, the tail of the inferior lobe 
of the pancreas drains separately into the mesenteric vein, for which 
reason it had to be resected in all such experiments. In other experiments 
(Fig. lOB), the lobar distribution of the different kinds of blood was just 
the opposite. The left lobes were now receiving the pancreatico-gastro-
duodeno-splenic blood, and the right lobes were receiving intestinal blood. 
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FIG. 11. Hepatocyte shadows traced during histopathologic examination. These were 
later cut out on standard paper and weighed as an index of hepatocyte size. The 
specimens depicted were from the experiment shown in Figure 2A. The right lobes 
with the large hepatic cells received venous blood from the pancreas, stomach, 
duodenum and spleen. The relatively shrunken left lobes with the small hepatocytes 
received intestinal blood. (By permission of Surgery, Gynecology and Obstetrics, 
137:179,1973.) 
The effect of this kind of splanchnic division operation could be 
displayed dramatically on histopathologic and other morphologic grounds 
within 30 to 60 days. The lobules receiving pancreatico-duodenal venous 
effluent were big compared to the lobular atrophy and reticulin collapse in 
tissue given intestinal blood. With Hand E stain, the individual 
hepatocytes on the side getting pancreatico-duodenal blood were obvi-
ously bigger and, in addition, there was evidence of hyperplasia. With a 
PAS stain, the same big hepatocytes contained much glycogen compared 
with the cells receiving nutrient-rich blood. 
To obtain a quantitative estimation of the hepatocyte size in these 
liver fragments, a tracing device was attached to the light microscope and 
large numbers of hepatocytes in each experiment were drawn on a 
standard thickness paper and weighed. In the experiment shown on Figure 
II, the hepatocytes on the left were from the liver side being perfused 
with intestinal blood. The right-sided and obviously much larger hepato-
cytes had their portal supply from the pancreatico-duodeno-splenic 
sources. The cell size data could then be summarized graphically as in 
Figure 12. 
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FIG. 12. The morphologic consequences of splanchnic venous flow division in the 
dogs shown in Figure 10 compared with normal dogs after 28 to 173 days, average 
73. The liver fractions which were perfused with venous blood from the pancreatic, 
gastroduodenal and splenic areas are shaded. Note that these portions gained weight 
and underwent an increase in hepatocyte size relative to the other side while the total 
liver weight to body weight ratios were little altered. One standard deviation is 
depicted graphically on the bar graphs and written out for the weight percentages. 
(By permission of Surgery, Gynecology and Obstetrics, 137:179,1973.) 
The key data of Figure 12 are on the right, in which the size units of 
these hepatocytes are indicated. In normal control animals the hepatocytes 
were of essentially equal size with very small standard deviation in the 
right as opposed to the left lobes. However, when pancreatico-duodeno-
splenic blood was diverted to the left hepatic lobes, the hepatocytes in this 
portion of the liver now became large in comparison to the hepatocytes in 
other liver fragments receiving intestinal blood. The same change occurred 
whether the pancreatico-duodeno-splenic blood was passed to the left or 
to the right side. 
In these splanchnic division experiments, the side receiving pancreatic 
blood underwent glycogen storage. Also, the various other biochemical 
studies including glucokinase, cyclic AMP and phosphorylase determina-
tions tended once more to show biochemical dissociation between the 
co-existing liver fragments. However, the results were far less predictable 
than with the originally employed split transposition. Because of this and 
because of the results I gave you a moment ago with split transposition 
animals made diabetic, we concluded that the hepatotrophic factors are 
mainly interrelationships of hormones rather than any single hormone, 
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that the master anabolic hormone was probably insulin with a highly 
significant interplay with glucagon and probably other catabolic hormones 
including epinephrine. We further concluded that nutritional factors 
probably played a significant but secondary role. The complexity, 
changeability, interdependence and importance of these hormone-
substrate relationships can be appreciated by perusing summary papers by 
Professors Hans Krebs, George Weber and others in the 1971 and 1972 
issues of Advances in Enzyme Regulation or by reading the brilliant 
summary of the implications of the hepatotrophic concept by Hans 
Popper, which is being published in this month's issue of Gastro-
enterology [23]. 
Diabetes and Splanchnic Division 
Although the results I just cited with the splanchnic division 
experiments were consistent with the conclusion that insulin was a 
hepatotrophic substance, the relative importance of insulin could still be 
debated. This question of the importance of insulin was examined in the 
splanchnic division model (Fig. 10) by the superimposition of alloxan 
diabetes and by total pan createctomy. This was done in five and six 
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FIG. 13. Right and left liver lobe weights, expressed as percentages of total liver 
mass, in normal dogs and in dogs undergoing chronic splanchnic division (Fig. lOA). 
Half of the latter animals were rendered diabetic, either with alloxan (four dogs) or 
by total pancreatectomy (six dogs). Note that the hypertrophy of the right lobes 
produced by the surgical procedure was nearly abolished by the creation of diabetes. 
N = Number of dogs in each experimental group. 
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animals, respectively, and the results compared with 12 nondiabetic 
controls as well as with a dozen nonoperated normal animals. The diabetic 
dogs were treated -with 15 to 20 units per day of NPH insulin for two 
months. 
The results were extremely clear cut. The right lobes of completely 
normal dogs weighed the expected 30% of total liver mass. In nondiabetic 
animals, the splanchnic division operation caused a great increase in the 
right lobes which were receiving the hormone-rich pancreatico-duodeno-
splenic blood, and striking atrophy of the left lobes which were receiving 
the nutritionally rich intestinal blood. This right lobar advantage was 
almost completely eliminated in the five animals which had alloxan 
diabetes established before the splanchnic division operation (Fig. 13). 
Almost exactly the same thing occurred in the animals with total 
pancreatectomy (Fig. 13). Bear in mind that these diabetic animals had to 
be treated with insulin which would eventually have been delivered in 
about the same proportions to both hepatic sides. 
Another fascinating aspect of this study was that DNA synthesis as 
measured by the tritiated thymidine technique was much greater on the 
hormone-fed right side in otherwise unaltered (nondiabetic) animals (Fig. 
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FIG. 14. DNA replication as measured by tritiated thymide uptake. The specific 
activity is expressed in percentages, the side with maximum uptake being assigned an 
arbitrary 100%. In normal dogs, there was no significant difference between the two 
sides. In the nondiabetic animals with chronic splanchnic division (Fig. 13A), the 
right lobes always had the greater activity. Note that the induction of diabetes 
reversed this pattern so that now the left lobes had the greater specific activity. 
N = Number of dogs in each experimental group. 
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14). The imposition of alloxan diabetes or the performance of total 
pancreatectomy completely reversed this situation. Now, the left, or 
nutritionally enriched liver lobes were predominant, thereby indicating 
that the dominant cell multiplication had shifted sides by the removal of 
endogenous insulin. 
I emphasized at the beginning and do so again that our main 
preoccupation for more than a decade has been with the chronic animal 
and not with acute experiments on regeneration. Nevertheless, I have 
already stated that we observed long ago that liver tissue undergoing 
glycogen storage and hypertrophy under favorable hepatotrophic condi-
tions also had evidence from old-fashioned mitotic indices of having 
relative hyperplasia. Consequently, it has been our tacit assumption that 
hepatotrophic factors are important to a full understanding of regenera-
tion, a position which is supported by the data on DNA synthesis I just 
gave you and by much more of our work which I do not have time to go 
into. Recently, many authorities have supported this contention, including 
Lee [18], Chandler [19], Sgro and Orloff [24] of San Diego and by the 
more recent publications of Fisher to which I referred earlier [21]. It is 
only fair to say that Bucher of Harvard has been skeptical about any 
central role of hepatotrophic factors in regeneration [25] . Price et al of 
Columbia have even claimed that hypertrophy and hyperplasia as affected 
by splanchnic hepatotrophic factors bear an inverse relationship to each 
other [26] . 
To summarize to this point, I have reviewed work carried out mainly 
during the past decade which indicates that substances in the splanchnic 
venous blood are influential in the maintenance of hepatic structure and 
function. These substances appear to be predominantly, although not 
necessarily exclusively, trace quantities of interreacting hormones of which 
insulin is thought to be the major anabolic hormone, balanced by the 
converse effects of glucagon and presumably other hormones as well. The 
interrelationship of the hepatotrophic factors rather than any single 
hormone or other substance is thought to be responsible for the changes in 
chemical composition, hepatocyte size and the capacity for regeneration 
which the presence or absence of these hepatotrophic factors can 
markedly influence. 
Clinical Application 
What are some of the clinical implications of this work? One could 
start with auxiliary liver transplantation or with regeneration but these 
topics have been discussed already. In addition, there are direct connec-
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tions of the hepatotrophic concept in the selection of portacaval shunt 
procedures. In patients who still have hepatopetal portal flow, the Warren 
shunt operation preserves, for liver perfusion, the hormone-rich pancreatic 
effluent, to say nothing of the intestinal venous drainage, while at the 
same time decompressing the gastro-esophageal varices. Because it retains 
maximally the perfusion of the liver by hepatotrophic portal factors, we 
believe in spite of its technical difficulties, that the Warren shunt is 
physiologically the most ideal shunt available today [27]. 
Glycogen Storage Disease 
With the Warren shunt, the objective is to preserve normal hepatic 
physiology insofar as possible. But it is becoming increasingly obvious that 
the deliberate diversion of hepatotrophic factors away from the liver may 
be of significant therapeutic benefit in certain inborn errors of metabo-
lism, of which I would like to mention two. 
Table 2. Children with Glycogen Storage Disease Treated 
at the University of Colorado by Portal Diversion 
Age Symptoms 
at Growth 
Case No. Operation Type Hypoglycemia Acidosis Retardation 
1* 8Y2 IIIB X X X 
(1963) 
2* 7 X X X 
(1968) 
3 7 X X X 
(1972) 
4 11 X X X 
(1972) 
5 10 VI X 
(1972) 
6 5 III X X X 
(1972) 
7 3 III X X X 
(1972) 
8 8 X X X 
(1973) 
9 13 X X X 
(1973) 
*These two patients had portacaval transposition. All others had end-to-side 
portacaval shunt. 
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The first is glycogen storage disease, a disorder for which we 
recommended and first performed portal diversion more than ten years 
ago [7]. We have now treated a total of nine patients (Table 2). The 
second patient died of a technical surgical accident following the 
unnecessarily complicated procedure of portacaval transposition, but the 
other eight are still alive after six months to more than a decade. The 
glycogen storage diseases have been Type 1, in which the enzyme 
deficiency responsible for hepatic glycogen accumulation is glucose-6-
phosphatase, Type III (or amylo-1-6-glucosidase deficiency) and Type VI 
in which the deficient enzyme is phosphorylase. Stunting of growth was 
present in all the cases (Table 2). The patients with Types I and IJI all had 
metabolic acidosis and episodic hypoglycemia that required frequent night 
feedings (Table 2). 
After portal diversion, the peripheral blood sugar response to a glucose 
meal was only a little prolonged in comparison to the preoperative 
study [28] . Thus, it would be a mistake in many of these cases, such as 
the child with Type I disease shown in Figure 15, to try to discontinue 
dietary management or to eliminate night feedings. Perhaps the reason that 
portacaval shunt did not produce a more dramatic glucose response what 
GLUCOSE' 
I"Q IIOOmO J60 
FIG. 15. Peripheral venous insulin and glucose values during oral glucose tolerance 
tests preoperatively (top) and two weeks after portacaval shunt (bottom). The arrow 
indicates the time of glucose ingestion. Note that the glucose curve is only slightly 
prolonged by the shunt, but that peripheral insulin levels have increased 
tremendously. 
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FIG. 16. Effect of parenteral hyperalimentation and end-to~ide portacaval shunt on 
the plasma lipids of a patient whose diagnosis was Type I glycogen storage disease 
(glucose-6-phosphatase deficiency). Note the rapid and relatively complete reversal of 
all abnormalities. (By permission of Annals of Surgery, 178 :525, 1973.) 
that nutritional diversion was accompanied by a concomitant increase in 
circulating insulin (Fig. 15). It is well known [29] that patients with 
glycogen storage disease have low venous insulins. as in the preoperative 
study shown in Figure 15. Presumably, bypassing the liver, which normally 
extracts more than half of the portal venous insulin content, accounts for 
the augmentation of peripheral insulin which, in tum, we believe is 
responsible for many of the beneficial effects of portacaval shun t in these 
patients. 
In contrast to the incomplete relief of hypoglycemia, all components 
of the hyperlipidemia which is characteristic of Type I disease are rapidly 
relieved by the procedure. In addition, there has been correction of other 
metabolic defects, including abnormal bleeding. uric acid elevations and 
deranged calcium metabolism as we have described fully in an article [28]. 
One of the most interesting findings in these patients has been the 
effect of portal diversion on body growth. In our original case, a 
remarkable growth spurt was noted which ended ten years later in a 
"super-sized" teenager. Accelerated height increases have been seen in all 
of our patients followed for longer times. After operation, these previously 
dwarfed children have grown at a rate of 5/10 to one full centimeter every 
month (Table 3). 
518 T. E. STARZL 
Table 3. 
Chronologie Age Time of Postopera tive 
at Operation Follow-up Height Increase 
Case No. (Years) (Months) (cm) 
1* 8Yz 113 47% 
3 7 11 Yz 11% 
4 11 11 5% 
5 10 8% 5% 
*These data have been published [28]. 
Comparison of the wrist and hand films before and 11\6 months after 
operation show the effects of doubling the bone age in the child shown in 
Figure 17. The bracket shown was 5 cm in length. In addition to the size 
change, note that mineralization has occurred and that new bones have 
appeared in the wrists. Circulating somatrophins were normal. The growth 
spurts may have been at least partially attributable to the increased 
distribution of insulin to the periphery, as I discussed earlier. In recent 
years, insulin has been recognized to be a major growth hormone 
comparable in potency to somatotrophin [29]. 
Earlier, I provided some data from dog experiments which I have 
summarized in Figure 18 in terms of human anatomy. This work, which 
permitted the delineation of nutritional from hormonal effects in portal 
blood, has indicated that the hormonal influences are the more profound. 
Of course, in the children we have been discussing, nutritional as well as 
hormonal bypass was achieved and both factors may have contributed to 
the outcome. 
In the dog experiments, there was shrinkage of the individual 
hepatocytes deprived of pancreatic blood. In the liver biopsies of our 
glycogen storage patients taken before and after portal diversion, there was 
a similar diminution in hepatocyte and lobular size. This observation 
explains, at least in part, why portal diversion has resulted in relief of 
hepatomegaly without, at the same time, resulting in a change in actual 
hepatic glycogen concentration. 
Idiopathic Hyperlipidemia 
Another example of the profound metabolic effects of portal diversion 
is its truly astonishing amelioration of homozygous Type II hyper-
lipidemia, a disease for which available therapy, including the ileal bypass 
of Buchwald and Varco [30], has not been very satisfactory. Sixteen 
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• GLYCOGENATION 
FIG. 18. Summary of the experimental results in the canine experiments in which 
one portion of the liver received portal venous inflow from the pancreas and the 
other portion received inflow from the intestine (prototype experiment as in Figure 
10). The "food dominated" hepatic fragment underwent atrophy and deglycogena-
tion whereas the "hormone dominated" fragment had hypertrophy, hyperplasia and 
glycogen storage. These experiments which permitted dissociation of nutritional and 
hormonal influences indicated that the latter were more influential than the former 
in affecting liver structure and function. (By permission of Annals of Surgery, 
178:525,1973.) 
months ago we performed a portacaval shunt on a l2-year-old girl who had 
suffered a major myocardial infarction and who had significant aortic 
~tenosis (60 mm Hg gradient), both presumably due to the deposition of 
xanthomas in her coronary arteries and aortic valve, despite therapy with 
diet, cholestramine, dextrothyroxin, chlofibrate and nicotinic acid. 
After the portacaval shunt there was prompt regression of the 
hyperlipoproteinemia and hypercholesterolemia coupled with a remark-
able subjective and objective clinical improvement [31]. The fall of the 
cholesterol values was from about 800 mg% preoperatively to just above 
the normal range six months later (Fig. 19). 
The visible xanthomas decreased in size and it is clear that a similar 
reversal is occurring in her coronary arterial and aortic valvular lesions. The 
therapeutic effect in this case may have been due to a relative turning off 
of lipoprotein synthesis in the liver. At her original biopsy the hepatocytes 
were full of rough endoplasmic reticulum. After operation, the hepato-
cytes shrank and glycogen granules were scarce. Rough endoplasmic 
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FIG. 19. Cholesterol concentrations before and for six months after portal diversion. 
The preoperative value represents the mean of nine determinations ± standard 
deviation. 
FIG. 20. (A) Complete portacaval shunt by which all nonhepatic splanchnic blood is 
diverted around the liver. In dogs, this procedure always lowers the serum 
concentration of cholesterol. (B) Selective diversion of the splanchnic blood. A t the 
.first stage the nutrient-rich intestinal blood is bypassed and subsequently the 
hormone-rich blood from upper splanchnic organs is rerouted. 
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reticulum was greatly decreased, to one-fourth or one-third of its original 
amount, as judged by a quantitative technique. Since rough endoplasmic 
reticulum is involved in lipoprotein synthesis, curtailment of this synthesis 
could be at least partly responsible for the improvement. 
The role of hepatotrophic factors in this antilipidemia effect is sug-
gested by the very simple experiment shown in Figure 20 which diverts 
intestinal nutrients around the liver by mesenteric-vena caval shunt. Later, 
hormone diversion can be added by a central portacaval shunt. Thus, in 
two stages the same thing is achieved as with a one-stage portal diversion. 
The same kind of result is almost always obtained in dogs and we think 
also in baboons. The mesenteric venous bypass has no effect on serum 
cholesterol concentrations, whereas when the pancreatic hormones are 
shunted at a second stage, the cholesterol starts down. Thus, we think the 
lipid lowering effect of portacaval shunt is from the shunting around the 
liver of hormones, particularly insulin. 
The remarkable effects of portal diversion on lipid metabolism have 
implications far beyond the treatment of a few children with inborn errors 
of metabolism. At stake may be the chance to treat many adults with 
premature atherosclerosis. 
Summary 
The conclusion from these experiments and observations of the last 15 
years is that hepatotrophic factors previously reported from our labora-
tories and by other investigators to be in splanchnic venous blood are, in 
fact, mainly trace quantities of hormones and, probably most importantly, 
insulin. However, it is the interrelationship of these hormones to each 
other and to nutritional substrate which is of key importance in the 
moment-to-moment regUlation of nutrient and hepatic homeostasis. These 
interrelationships and their profound effects constitute a central and 
previously undefined fact of liver physiology that should reconcile a 
number of previously divergent opinions about portoprival syndromes, 
mechanisms of hepatic atrophy and hyperplasia, control of liver regenera-
tion, and the effects of portal diversion for glycogen storage disease and 
idiopathic hyperlipidemia to mention only a few random examples. 
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